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Abstract
Background: In the present study the efficacy and cross protection of a novel ready-to-use combination vaccine,
Porcilis® Ery + Parvo + Lepto, against swine leptospirosis, was investigated. The octavalent vaccine contains inactivated
antigens of Erysipelothrix rhusiopathiae, Parvovirus and 6 Leptospira interrogans sensu lato strains of serogroups Canicola,
Icterohaemorrhagiae, Grippotyphosa, Australis (Bratislava), Pomona and Tarassovi. In this study ninety pigs were
vaccinated twice with Porcilis® Ery + Parvo + Lepto at six and ten weeks of age and ninety age and source-matched
animals served as unvaccinated control. Two weeks after booster vaccination, groups of vaccinated and control pigs
(ten pigs per group) were challenged with fresh virulent cultures of either of the nine different challenge strains.
Compared to the vaccine strains the challenge strains were heterologous strains of the same serovar or of a different
serovar within the same serogroup. The challenge strains tested were of serovar Canicola, Icterohaemorrhagiae,
Copenhageni (serogroup Icterohaemorrhagiae), Grippotyphosa, Bananal/Liangguan (serogroup Grippotyphosa),
Pomona, Tarassovi and Vughia (serogroup Tarassovi).
Results: After the different challenges most control animals became leptospiraemic for 2–7 days. The vaccinated
pigs remained blood culture negative except for two animals after serovar Icterohaemorrhagiae and two animals
after serovar Tarassovi challenge which became leptospiraemic for only 1 day. The incidence of Leptospiraemia
(as determined by blood culture) was significantly less in vaccinates compared to the controls after all challenges.
The vaccine also prevented renal infection and urinary shedding after serovar Canicola challenge. The other serovars
did not induce detectable renal infection or urinary shedding.
Conclusion: The present study demonstrates that the new combination vaccine Porcilis® Ery + Parvo + Lepto induces
significant (cross) protection against nine different serovars within the serogroups Canicola, Icterohaemorrhagiae,
Grippotyphosa, Australis (Bratislava), Pomona and Tarassovi.
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Background
Leptospirosis, caused by Leptospira interrogans sensu lato,
is a cause of reproductive failure in pigs worldwide, which
manifests itself as abortions or the birth at term of a vari-
able number of mummified, autolysed, stillborn and/or
weak piglets [1–4]. Leptospirosis in pigs, as in other animals
and humans, is difficult to diagnose and its incidence is
most probably underestimated. Culture, serology and PCR
often are negative even when active infection is present. In
addition, in sows, the clinical signs of Leptospira infection
are few, vague and non-specific or absent.
Reports on swine relevant serovars are scars and the
few reports that are available indicate that serogroups
Pomona, Tarassovi, Australis (Bratislava), Grippoty-
phosa, Icterohaemorrhagiae and Canicola are most
commonly isolated from pigs with reproductive prob-
lems [3–7].
Recently, we reported on the development of a new
ready-to-use combination product (Porcilis® Ery + Parvo +
Lepto), containing inactivated Erysipelothrix rhusiopathiae,
Parvovirus, and Leptospira interrogans sensu lato serogroups
Canicola, Icterohaemorrhagiae, Australis (Bratislava), Grip-
potyphosa, Pomona and Tarassovi [8]. In that study it
was demonstrated that the vaccine can be safely used in
gilts and sows and induces significant protection, for
the duration of at least one year, against serovar Po-
mona induced clinical signs, leptospiraemia and foetal
death. In addition, protection against Pomona associ-
ated reproductive failure was confirmed under field
conditions where a significant reduction in abortion
rate was observed.
It is generally assumed that Leptospira vaccines induce
protection within serogroups, i.e. that one serovar induces
cross-protection against other serovars within the same
serogroup but evidence, especially in pigs, is limited [9, 10].
The objective of the present study was to evaluate efficacy
of the new combination vaccine Porcilis® Ery + Parvo +
Lepto against nine different homologous as well as heterol-
ogous Leptospira serovar challenge strains.
Results
Serology
On the day of challenge the vaccinated pigs had various
levels of serogroup specific microscopic agglutination
(MAT) titres whereas the controls remained seronegative
(Table 1). Highest responses were found for serogroups
Canicola and Australis (Bratislava) whereas the serogroups
Icterohaemorrhagiae (serovar Copenhageni) and Tarassovi
(serovar Gatuni) vaccine strains showed only poor anti-
body responses after vaccination. Four weeks after chal-
lenge, most pigs showed high MAT titres except for the
serovar Grippotyphosa and serovar Tarassovi challenge
controls which showed a poor response.
Clinical signs and rectal temperature
An increase in rectal temperature was found on post-
challenge day 2 or 3 in control animals after serovar
Icterohaemorrhagiae and serovar Canicola challenge, re-
spectively (Fig. 1). These temperature effects (AUC) were
significantly different between vaccinates and controls;
p = 0.012 and p = 0.010 after serovar Icterohaemorrhagiae
and serovar Canicola challenge, respectively. After the
other serovar challenges no effects on rectal temperature
were observed. Further no challenge related clinical signs
were observed (not shown).
Re-isolation of challenge organisms from blood
After the different challenges most control animals became
leptospiraemic for 2–7 days (Table 2). The vaccinated pigs
remained blood culture negative except for two animals
after serovar Icterohaemorrhagiae and 2 pigs after serovar
Tarassovi challenge which became leptospiraemic for only
1 day. The number of pigs infected was significantly
less in vaccinates compared to controls (Fisher’s exact)
after all challenges except after serovar Tarassovi chal-
lenge where 2/10 vaccinates were infected compared to 6/
10 controls (p = 0.1698). However, the number of positive
blood isolations was significantly reduced (GEE) after
challenge with this serovar (p = 0.0285).
Re-isolation of challenge organisms from urine and kidney
With the exception of serovar Canicola and serovar
Icterohaemorrhagiae all urine cultures remained culture
negative. After Canicola challenge all ten control animals
showed leptospiruria on one or more days (Table 3).
Also six kidney cultures became positive in the control
group. The urine and kidney cultures of the vaccine group
remained negative. Both the number of pigs shedding and
the number of positive kidney cultures were significantly
different between vaccinates and controls.
After Icterohaemorrhagiae challenge only one control
animal became urine culture positive and all kidney cul-
tures remained negative.
Discussion
In this study, all different serovar challenge strains in-
duced leptospiraemia in the controls. An increased rec-
tal temperature was only measured after serovar Canicola
and serovar Icterohaemorrhagiae challenge and significant
leptospiruria was only observed after serovar Canicola chal-
lenge. The new octavalent combination vaccine protected
against those phenomena and induced cross-protection be-
tween different serovars within serogroups. In addition, we
demonstrated cross-protection within serogroups across
species level as the serogroup Tarassovi vaccine strain and
the two Tarassovi challenge strains represent three dif-
ferent species; Leptospira santarosai, Leptospira weilii
and Leptospira borgpetersenii, respectively.
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After vaccination remarkable differences in serological
responses were found. The vaccine induced high serogroup
specific MAT titres against Canicola and Australis whereas
MAT titres to serogroups Tarassovi and Icterohaemor-
rhagiae appeared either absent or very low. Even in the
absence of detectable antibodies the vaccine protected
against challenge with two different serovars of serogroup
Tarassovi and two different serovars of serogroup
Icterohaemorrhagiae, indicating that detectable MAT ti-
tres are not required for protection. This is consistent with
results of Whyte et al. [11] who also reported protection
against Pomona in the absence of significant Pomona
MAT titres. It is possible that very low concentrations
(below the limit of quantification of the assay) of serum
agglutinating antibodies may protect against infection.
This is in line with several earlier studies [12–14] which
Table 1 Average MAT titres after vaccination and challenge. Pigs were vaccinated twice (4-week interval) and challenged with
different Leptospira serovar (sv) and serogroup (sg) challenge strains, 6 weeks after first vaccination. MAT titres homologous to
challenge strain
avg MAT titres ± SD (log2), weeks after first vaccination
n group Challenge with 0 4 6 10
9 vaccine sv Canicola <2 <2 9.6 ± 2.0 9.6 ± 1.3
10 control sg Canicola <2 <2 <2 10.3 ± 1.1
10 vaccine sv Copenhageni <2 <2 3.8 ± 1.2 9.6 ± 1.0
10 control sg Icterohaemorrhagiae <2 <2 <2 10.3 ± 0.7
10 vaccine sv Icterohaemorrhagiae <2 <2 <2 9.1 ± 3.3
10 control sg Icterohaemorrhagiae <2 <2 <2 8.7 ± 1.4
10 vaccine sv Bananal / Liangguan <2 <2 6.9 ±1.4 9.3 ± 0.8
9 control sg Grippotyphosa <2 <2 <2 9.1 ± 0.8
8 vaccine sv Grippotyphosa <2 <2 4.6 ± 2.4 7.6 ± 1.3
10 control sg Grippotyphosa <2 <2 <2 2.0 ± 1.8
10 vaccine sv Bratislava <2 6.9 ± 1.2 10.4 ± 0.8 10.5 ± 1.1
9 control sg Australis <2 <2 <2 9.9 ± 1.2
9 vaccine sv Pomona <2 <2 5.0 ± 4.0 6.7 ± 3.2
10 control sg Pomona <2 <2 <2 9.6 ± 0.8
10 vaccine sv Vughia <2 <2 <2 8.5 ± 0.8
10 control sg Tarassovi <2 <2 <2 9.5 ± 1.0
10 vaccine sv Tarassovi <2 <2 2.0 ± 3.2 8.0 ± 1.3
10 control sg Tarassovi <2 <2 <2 4.3 ± 1.3
a b
Fig. 1 Time-course of average rectal temperature (± sem) after challenge. Groups of ten pigs were vaccinated twice, 4 weeks apart, with Porcilis®
Ery + Parvo + Lepto (vaccinates) or were left unvaccinated (controls). Two weeks after booster vaccination, pigs were challenged with Leptospira
serovar Icterohaemorrhagiae (a) or serovar Canicola (b)
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showed that sera from vaccinated animals or humans
with low or undetectable concentrations of agglutinating
antibodies afforded protection in the passive hamster pro-
tection test.
Striking differences in serological responses were also
found after infection of control animals. Most serovars
induced high MAT titres after challenge. However, sero-
var Grippotyphosa and serovar Tarassovi hardly induced
MAT titres whereas other serovars within the Grippoty-
phosa and Tarassovi serogroups (Bananal/Liangguang
and Vughia, respectively) induced high titres. This differ-
ence may be explained by the observation that the first
two strains appeared less virulent and had a shorter
duration of leptospiraemia. This result underlines the
limited value of serology in diagnosing Leptospira related
problems in pigs as pigs can be infected without show-
ing a serological response.
Except for serovar Canicola renal infection or leptos-
piruria was not observed in this study. This is in contrast
to the results of Hodges et al. [2] and Whyte et al. [11]
who found urinary shedding after serovar Pomona chal-
lenge and Ellis et al. [15] who found renal infection after
serovar Bratislava challenge. This difference may be due
to the differences in age or susceptibility of the pigs, dif-
ferences in the challenge strains or a different detection
limit between the diagnostic methods.
Table 2 Reisolation of Leptospira from blood. Pigs were vaccinated twice (4-week interval) and challenged with different Leptospira
serovar (sv) and serogroup (sg) challenge strains, 6 weeks after first vaccination. A pig was considered infected if at least once a
positive blood isolation was found. n.a. = not applicable
reisolation of Leptospira from blood on post-challenge day # pigs infected # blood isolations
n group challenge with 0 1 2 3 4 7 10
9 vaccine sv Canicola 0 0 0 0 0 0 0 0** n.a.
10 control sg Canicola 0 10 10 10 10 1 0 10 n.a.
10 vaccine sv Copenhageni 0 0 0 0 0 0 0 0** n.a.
10 control sg Icterohaemorrhagiae 0 10 10 8 4 1 0 10 n.a.
10 vaccine sv Icterohaemorrhagiae 0 2 0 0 0 0 0 2** 2**
10 control sg Icterohaemorrhagiae 0 9 6 2 0 0 0 9 17
10 vaccine sv Bananal / Liangguan 0 0 0 0 0 0 0 0** n.a.
9 control sg Grippotyphosa 0 6 8 6 2 0 0 8 n.a.
8 vaccine sv Grippotyphosa 0 0 0 0 0 0 0 0** n.a.
10 control sg Grippotyphosa 0 6 1 0 0 0 0 6 n.a.
10 vaccine sv Bratislava 0 0 0 0 0 0 0 0** n.a.
9 control sg Austrais 0 6 4 0 0 0 0 6 n.a.
9 vaccine sv Pomona 0 0 0 0 0 0 0 0** n.a.
10 control sg Pomona 0 10 10 10 9 2 0 10 n.a.
10 vaccine sv Vughia 0 0 0 0 0 0 0 0** n.a.
10 control sg Tarassovi 0 10 9 1 1 0 0 10 n.a.
10 vaccine sv Tarassovi 0 2 0 0 0 0 0 2 2*
10 control sg Tarassovi 0 6 2 1 1 0 0 6 10
* p<0.05, ** p<0.01
Table 3 Reisolation of Leptospira from urine and kidney. Pigs were vaccinated twice (4-week interval) and challenged with different
Leptospira serovar (sv) and serogroup (sg) challenge strains, 6 weeks after first vaccination. Urine was sampled regularly and kidney
samples were collected during necropsy 4w after challenge. A pig was considered shedding if at least once a positive urine isolation
was found
reisolation of Leptospira from urine on post-challenge day # pigs shedding # Kidney positive
n group challenge with 0 14 17 21 24 28
9 vaccine sv Canicola 0 0 0 0 0 0 0** 0**
10 control sg Canicola 0 9 9 9 7 6 10 6
10 vaccine sv Copenhageni 0 0 0 0 0 0 0 0
10 control sg Icterohaemorrhagiae 0 0 0 0 1 1 1 0
** p<0.01
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In this study the vaccine completely prevented renal
leptospirosis as well as urinary shedding after serovar
Canicola challenge. Hodges [16] also observed prevention
of leptospiruria after four repeated vaccinations and a
natural serovar Pomona challenge whereas in the studies
described by Hodges et al. [2] and Whyte et al. [11] nei-
ther vaccine did prevent urinary shedding after serovar
Pomona challenge. Prevention of Leptospiruria is an
important feature of a successful vaccine as urinary
shedding is the main source of transmission to naïve
animals and men.
Conclusion
The present study demonstrates that the new combination
vaccine Porcilis® Ery + Parvo + Lepto induces significant
(cross) protection against nine different serovars within the
serogroups Canicola, Icterohaemorrhagiae, Grippotyphosa,
Australis (Bratislava), Pomona and Tarassovi.
Methods
Vaccine
A vaccine containing inactivated Erysipelothrix rhusio-
pathiae, Parvo virus, Leptospira interrogans (sensu lato)
serogroups Canicola, Icterohaemorrhagiae, Australis
(Bratislava), Grippotyphosa, Pomona and Tarassovi and
Diluvac Forte® adjuvant (Porcilis® Ery + Parvo + Lepto,
MSD Animal Health).
Leptospira strains
The vaccine strains and challenge strains evaluated in this
study are shown in Table 4. All strains were obtained at
an unknown passage level from Dr. C. Bolin, (USDA,
NADC,USA), Dr R. Hartskeel (KIT, Amsterdam, The
Netherlands), Public Health Laboratory Service, UK or
from Queensland health Science Services, Australia.
After arrival the strains had 2–3 EMJH medium pas-
sages after which they were stored in liquid nitrogen.
The vaccine strains had 5–7 further medium passages
before they were used in the vaccine. The challenge
strains were either used after two additional medium
passages (serovars Grippotyphosa, Bratislava, Vughia and
Tarassovi) or after hamster passage followed by two add-
itional medium passages (serovars Canicola, Copenhageni,
Icterohaemorrhagiae, Bananal/Lianguang, Pomona).
Study design
Nine different vaccination-challenge trials were performed.
In total one hundred and eighty 6-week-old pigs, with
undetectable levels of serum antibodies against Leptos-
pira serogroups Canicola, Icterohaemorrhagiae, Australis
(Bratislava), Grippotyphosa, Pomona and Tarassovi, were
selected. Ninety pigs were vaccinated twice with Porcilis®
Ery + Parvo + Lepto with a 4-week interval between the
vaccinations. The other ninety pigs were left unvaccinated
and served as challenge controls. Two weeks after booster
vaccination, groups of vaccinated and control pigs (ten
pigs per group) were challenged with fresh cultures of one
of the nine different virulent Leptospira challenge strains
(109 bacteria/ml). Challenge was done by intra-peritoneal
(IP) injection of 20 ml and conjunctival instillation
(both eyes) of 0.25 ml culture per eye. The conjunctival
challenge was repeated one day later. The challenge strains
Table 4 Leptospira strains used for vaccine / challenge
Species Serogroup Serovar Strain Originally isolated from
Leptospira interrogans Canicola Portland-verea Ca-12-000 human blood, 1964, Jamaica
Leptospira interrogans Canicolab Moulton pig urine, 2004, Netherlands
Leptospira interrogans Icterohaemorrhagiae Copenhagenia Ic-02-001 rat kidney, 1978, USA
Leptospira interrogans Copenhagenib CF1 dog, 1969, Puerto Rico
Leptospira interrogans Icterohaemorrhagiaeb Verdun human, 1917, France
Leptospira kirschneri Grippotyphosa Dadasa Gr-01-005 kidney aborted piglet, 1983, USA
Leptospira kirschneri Bananal/Lianguangb 11808 shrew, 1972, USA
Leptospira kirschneri Grippotyphosab 142 horse eye, 1997 Germany
Leptospira interrogans Australis Bratislavaa As-05-073 pig placenta, 1989, USA
Leptospira interrogans Bratislavab X35IM-001 pig, 1990, USA
Leptospira interrogans Pomona Pomonaa Po-01-000 human blood, 1937, Australia
Leptospira interrogans Pomonab 02-0162 not known
Leptospira santarosai Tarassovi Gatunia X345 human blood, 1938, Russia
Leptospira weilii Vughiab L100 pig kidney, 2001, China
Leptospira borgpetersenii Tarassovib Perepelitsin human blood, 1941, Russia
avaccine strain
bchallenge strain
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used were heterologous isolates of the same serovar as well
as heterologous serovar strains within the same serogroup
compared to the vaccine strains (Table 4).
Blood samples were taken for serology, using the micro-
scopic agglutination test (MAT), after vaccination and chal-
lenge. Blood and urine samples were taken before and after
challenge to isolate the challenge strain. The pigs were ob-
served regularly for clinical signs, including lethargy and
anorexia for up to 4 weeks. Rectal temperature was mea-
sured just before challenge and on days 1, 2, 3, 4, 7 and 10
after challenge.
The pigs were euthanized 4 weeks after challenge. Nec-
ropsy was performed and the internal organs were inspected
for abnormalities. Kidney samples were taken for re-
isolation of challenge organisms.
Before challenge six animals were culled because of
aspecific causes such as gastric torsion, pericarditis and
locomotory problems, implying that a few challenge
groups consisted of less than ten animals.
Serology
Blood samples were collected from each pig on the day
of first vaccination, day of booster vaccination, day of
challenge and 4 weeks after challenge into Serum Sep.
Clot Activator tubes (without anticoagulant for prepar-
ation of serum). The serum samples were stored frozen
until analysis. Serogroup specific agglutination titres
were determined in the microscopic agglutination
(MAT) test as described previously [17]. Titres <2 log2
are regarded as negative. For calculation purposes <2
was replaced by 1.
Isolation of challenge organisms from blood or urine
To isolate the challenge strain, blood samples were taken
into heparinized tubes, just before challenge and on days
1, 2, 3, 4, 7 and 10 post-challenge. Urine was sampled
just before challenge and on days 14, 17, 21, 24 and 28
post-challenge for re-isolation of challenge strain.
Blood (heparinized) or urine samples (0.5 ml) were
added to 10 ml of liquid EMJH medium containing
200 μg/ml 5-fluorouracil and 1 % (v/v) rabbit serum
negative for agglutinating antibodies against the 6 differ-
ent serovars included in the vaccine. The cultures were
incubated at 28–30 °C, and observed fortnightly using
dark-field microscopy for a total of at least 8 weeks before
negative cultures were discarded. The identity of the isolates
was confirmed in the MAT test using specific anti-sera.
Isolation of challenge organisms from kidney
At necropsy a 1–2 g sample was taken from the renal cortex
of one kidney of each pig. The kidney samples were put into
liquid EMJH medium (containing 5-fluorouracil and nega-
tive rabbit serum) and homogenised with an Ultraturrax
homogeniser. A 100-fold dilution of kidney homogenate
was cultured in EMJH and examined as described above.
Statistical analysis
The level of significance α was set at 0.05 and all tests
were two sided. Statistical analyses were carried out using
the statistical programme SAS V9.1 or higher (SAS
Institute Inc. Cary NC, USA).
Rectal temperature
The time course of the temperature responses following
challenge was visually inspected. Only in case the controls
had a response after challenge, the effect of vaccination on
rectal temperature was evaluated. The Area under the
Curve (AUC) of the rectal temperature over time was cal-
culated by the linear trapezoidal rule and using the pre-
challenge data as baseline [18, 19]. The AUC was analysed
by Analysis of Variance (ANOVA).
Bacterial isolation from blood
The proportion of infected pigs, defined as a pig having
at least one positive blood re-isolation after challenge,
was analyzed by Fisher’s exact test and the relative per-
centage protection was derived from the formula (1 − % in-
fected Vaccine / % infected Control) × 100 %. In studies
where in the vaccinated pigs not all post-challenge blood
samples remained negative, the incidence of a positive
blood sample was analyzed by Generalized Estimating
Equations (GEE), accounting for the repeated measure-
ments structure of the data [20] and using a log binomial
regression model to estimate the relative risk and derived
relative percentage protection [20, 21]. The p-value was
based on the empirical standard error.
Bacterial isolation from kidney and urine
Bacterial re-isolation data from urine and kidney, cate-
gorized as positive or negative were evaluated by Fisher’s
exact test [19].
Abbreviations
AUC: area under the curve; Ery: Erysipelothrix rhusiopathiae; GEE: Generalized
Estimating Equations; MAT: microscopic agglutination test; SD: standard
deviation; SEM: standard error of the mean.
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